APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sitagliptin

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Sitagliptin Market Outlook and Growth Opportunities 2026

19 December 2025192 pages

Choose your research edition.

Industry ResearchSitagliptin Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Sitagliptin Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Sitagliptin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sitagliptin Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Sitagliptin Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sitagliptin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Sitagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sitagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sitagliptin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Sitagliptin market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Sitagliptin market include Yonta, Baoling Pharma, Merck, De Xiang Pharmaceutical&Chemicals, Haikang Pharma and Phebra, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sitagliptin market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sitagliptin and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sitagliptin sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sitagliptin market size, projected growth trends, production technologies, key applications, and end-use industries.

Sitagliptin Segment by Company

Yonta

Baoling Pharma

Merck

De Xiang Pharmaceutical&Chemicals

Haikang Pharma

Phebra

Sitagliptin Segment by Type

Injection

Tablets

Sitagliptin Segment by Application

Diabetes

Epilepsy

Others

Sitagliptin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Sitagliptin status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Sitagliptin market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Sitagliptin significant trends, drivers, influence factors in global and regions.

6. To analyze Sitagliptin competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sitagliptin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sitagliptin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sitagliptin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sitagliptin market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Sitagliptin industry.

Chapter 3: Detailed analysis of Sitagliptin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Sitagliptin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Sitagliptin in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Sitagliptin Industry Trends Table 2. Sitagliptin Industry Drivers Table 3. Sitagliptin Industry Opportunities and Challenges Table 4. Sitagliptin Industry Restraints Table 5. Global Sitagliptin Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Sitagliptin Revenue Share by Company (2021-2026) Table 7. Global Sitagliptin Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Sitagliptin Sales Volume Share by Company (2021-2026) Table 9. Global Sitagliptin Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Sitagliptin Company Ranking, (2024-2026) & (USD Million) Table 11. Global Sitagliptin Key Company Manufacturing Base & Headquarters Table 12. Global Sitagliptin Company, Product Type & Application Table 13. Global Sitagliptin Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Sitagliptin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Injection Table 18. Significant Companies of Tablets Table 19. Global Sitagliptin Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Sitagliptin Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Sitagliptin Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Sitagliptin Sales Volume Share by Type (2021-2026) Table 23. Global Sitagliptin Sales Volume Share by Type (2027-2032) Table 24. Global Sitagliptin Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Sitagliptin Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Sitagliptin Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Sitagliptin Sales Value Share by Type (2021-2026) Table 28. Global Sitagliptin Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Diabetes Table 30. Significant Companies of Epilepsy Table 31. Significant Companies of Others Table 32. Global Sitagliptin Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Sitagliptin Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Sitagliptin Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Sitagliptin Sales Volume Share by Application (2021-2026) Table 36. Global Sitagliptin Sales Volume Share by Application (2027-2032) Table 37. Global Sitagliptin Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Sitagliptin Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Sitagliptin Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Sitagliptin Sales Value Share by Application (2021-2026) Table 41. Global Sitagliptin Sales Value Share by Application (2027-2032) Table 42. Global Sitagliptin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Sitagliptin Sales by Region (2021-2026) & (K Units) Table 44. Global Sitagliptin Sales Market Share by Region (2021-2026) Table 45. Global Sitagliptin Sales by Region (2027-2032) & (K Units) Table 46. Global Sitagliptin Sales Market Share by Region (2027-2032) Table 47. Global Sitagliptin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Sitagliptin Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Sitagliptin Sales Value Share by Region (2021-2026) Table 50. Global Sitagliptin Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Sitagliptin Sales Value Share by Region (2027-2032) Table 52. Global Sitagliptin Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Sitagliptin Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Sitagliptin Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Sitagliptin Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Sitagliptin Sales by Country (2021-2026) & (K Units) Table 57. Global Sitagliptin Sales Market Share by Country (2021-2026) Table 58. Global Sitagliptin Sales by Country (2027-2032) & (K Units) Table 59. Global Sitagliptin Sales Market Share by Country (2027-2032) Table 60. Global Sitagliptin Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Sitagliptin Sales Value Market Share by Country (2021-2026) Table 62. Global Sitagliptin Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Sitagliptin Sales Value Market Share by Country (2027-2032) Table 64. Yonta Company Information Table 65. Yonta Business Overview Table 66. Yonta Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Yonta Sitagliptin Product Portfolio Table 68. Yonta Recent Development Table 69. Baoling Pharma Company Information Table 70. Baoling Pharma Business Overview Table 71. Baoling Pharma Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Baoling Pharma Sitagliptin Product Portfolio Table 73. Baoling Pharma Recent Development Table 74. Merck Company Information Table 75. Merck Business Overview Table 76. Merck Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Merck Sitagliptin Product Portfolio Table 78. Merck Recent Development Table 79. De Xiang Pharmaceutical&Chemicals Company Information Table 80. De Xiang Pharmaceutical&Chemicals Business Overview Table 81. De Xiang Pharmaceutical&Chemicals Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. De Xiang Pharmaceutical&Chemicals Sitagliptin Product Portfolio Table 83. De Xiang Pharmaceutical&Chemicals Recent Development Table 84. Haikang Pharma Company Information Table 85. Haikang Pharma Business Overview Table 86. Haikang Pharma Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Haikang Pharma Sitagliptin Product Portfolio Table 88. Haikang Pharma Recent Development Table 89. Phebra Company Information Table 90. Phebra Business Overview Table 91. Phebra Sitagliptin Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Phebra Sitagliptin Product Portfolio Table 93. Phebra Recent Development Table 94. Key Raw Materials Table 95. Raw Materials Key Suppliers Table 96. Sitagliptin Distributors List Table 97. Sitagliptin Customers List Table 98. Research Programs/Design for This Report Table 99. Authors List of This Report Table 100. Secondary Sources Table 101. Primary Sources List of Figures Figure 1. Sitagliptin Product Image Figure 2. Global Sitagliptin Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sitagliptin Sales Value (2021-2032) & (US$ Million) Figure 4. Global Sitagliptin Sales (2021-2032) & (K Units) Figure 5. Global Sitagliptin Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Sitagliptin Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Injection Image Figure 10. Tablets Image Figure 11. Global Sitagliptin Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Sitagliptin Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Sitagliptin Sales Volume Share by Type (2021-2032) Figure 14. Global Sitagliptin Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Sitagliptin Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Sitagliptin Sales Value Share by Type (2021-2032) Figure 17. Diabetes Image Figure 18. Epilepsy Image Figure 19. Others Image Figure 20. Global Sitagliptin Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Sitagliptin Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Sitagliptin Sales Volume Share by Application (2021-2032) Figure 23. Global Sitagliptin Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Sitagliptin Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Sitagliptin Sales Value Share by Application (2021-2032) Figure 26. Global Sitagliptin Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Sitagliptin Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Sitagliptin Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Sitagliptin Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Sitagliptin Sales Value (2021-2032) & (US$ Million) Figure 31. North America Sitagliptin Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Sitagliptin Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Sitagliptin Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Sitagliptin Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Sitagliptin Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Sitagliptin Sales Value (2021-2032) & (US$ Million) Figure 37. South America Sitagliptin Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Sitagliptin Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Sitagliptin Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Sitagliptin Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Sitagliptin Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Sitagliptin Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Sitagliptin Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Sitagliptin Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Tablets
Applications
  • Diabetes
  • Epilepsy
  • Others
Companies covered
  • Yonta
  • Baoling Pharma
  • Merck
  • De Xiang Pharmaceutical&Chemicals
  • Haikang Pharma
  • Phebra

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sitagliptin Sales Value (2021-2032)
  4. 1.2.2 Global Sitagliptin Sales Volume (2021-2032)
  5. 1.2.3 Global Sitagliptin Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Sitagliptin Market Dynamics
  1. 2.1 Sitagliptin Industry Trends
  2. 2.2 Sitagliptin Industry Drivers
  3. 2.3 Sitagliptin Industry Opportunities and Challenges
  4. 2.4 Sitagliptin Industry Restraints
3 Sitagliptin Market by Company
  1. 3.1 Global Sitagliptin Company Revenue Ranking in 2025
  2. 3.2 Global Sitagliptin Revenue by Company (2021-2026)
  3. 3.3 Global Sitagliptin Sales Volume by Company (2021-2026)
  4. 3.4 Global Sitagliptin Average Price by Company (2021-2026)
  5. 3.5 Global Sitagliptin Company Ranking (2024-2026)
  6. 3.6 Global Sitagliptin Company Manufacturing Base and Headquarters
  7. 3.7 Global Sitagliptin Company Product Type and Application
  8. 3.8 Global Sitagliptin Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Sitagliptin Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Sitagliptin Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Sitagliptin Market by Type
  1. 4.1 Sitagliptin Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Tablets
  4. 4.2 Global Sitagliptin Sales Volume by Type
  5. 4.2.1 Global Sitagliptin Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Sitagliptin Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Sitagliptin Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Sitagliptin Sales Value by Type
  9. 4.3.1 Global Sitagliptin Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Sitagliptin Sales Value by Type (2021-2032)
  11. 4.3.3 Global Sitagliptin Sales Value Share by Type (2021-2032)
5 Sitagliptin Market by Application
  1. 5.1 Sitagliptin Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Epilepsy
  4. 5.1.3 Others
  5. 5.2 Global Sitagliptin Sales Volume by Application
  6. 5.2.1 Global Sitagliptin Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sitagliptin Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Sitagliptin Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Sitagliptin Sales Value by Application
  10. 5.3.1 Global Sitagliptin Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Sitagliptin Sales Value by Application (2021-2032)
  12. 5.3.3 Global Sitagliptin Sales Value Share by Application (2021-2032)
6 Sitagliptin Regional Sales and Value Analysis
  1. 6.1 Global Sitagliptin Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sitagliptin Sales by Region (2021-2032)
  3. 6.2.1 Global Sitagliptin Sales by Region: 2021-2026
  4. 6.2.2 Global Sitagliptin Sales by Region (2027-2032)
  5. 6.3 Global Sitagliptin Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Sitagliptin Sales Value by Region (2021-2032)
  7. 6.4.1 Global Sitagliptin Sales Value by Region: 2021-2026
  8. 6.4.2 Global Sitagliptin Sales Value by Region (2027-2032)
  9. 6.5 Global Sitagliptin Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Sitagliptin Sales Value (2021-2032)
  12. 6.6.2 North America Sitagliptin Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Sitagliptin Sales Value (2021-2032)
  15. 6.7.2 Europe Sitagliptin Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Sitagliptin Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Sitagliptin Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Sitagliptin Sales Value (2021-2032)
  21. 6.9.2 South America Sitagliptin Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Sitagliptin Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Sitagliptin Sales Value Share by Country, 2025 VS 2032
7 Sitagliptin Country-level Sales and Value Analysis
  1. 7.1 Global Sitagliptin Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Sitagliptin Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Sitagliptin Sales by Country (2021-2032)
  4. 7.3.1 Global Sitagliptin Sales by Country (2021-2026)
  5. 7.3.2 Global Sitagliptin Sales by Country (2027-2032)
  6. 7.4 Global Sitagliptin Sales Value by Country (2021-2032)
  7. 7.4.1 Global Sitagliptin Sales Value by Country (2021-2026)
  8. 7.4.2 Global Sitagliptin Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Sitagliptin Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Sitagliptin Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Sitagliptin Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Sitagliptin Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Sitagliptin Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Sitagliptin Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Sitagliptin Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Sitagliptin Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Sitagliptin Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Sitagliptin Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Sitagliptin Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Sitagliptin Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Sitagliptin Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Sitagliptin Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Sitagliptin Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Sitagliptin Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Sitagliptin Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Sitagliptin Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Sitagliptin Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Sitagliptin Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Sitagliptin Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Sitagliptin Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Sitagliptin Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Sitagliptin Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Sitagliptin Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Sitagliptin Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Sitagliptin Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Sitagliptin Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Sitagliptin Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Sitagliptin Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Sitagliptin Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Sitagliptin Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Sitagliptin Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Sitagliptin Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Sitagliptin Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Sitagliptin Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Sitagliptin Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Sitagliptin Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Sitagliptin Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Sitagliptin Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Sitagliptin Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Sitagliptin Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Sitagliptin Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Sitagliptin Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Sitagliptin Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Sitagliptin Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Sitagliptin Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Sitagliptin Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Sitagliptin Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Sitagliptin Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Sitagliptin Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Sitagliptin Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Sitagliptin Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Sitagliptin Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Sitagliptin Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Sitagliptin Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Sitagliptin Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Sitagliptin Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Sitagliptin Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Sitagliptin Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Sitagliptin Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Sitagliptin Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Sitagliptin Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Sitagliptin Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Sitagliptin Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Sitagliptin Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Sitagliptin Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Sitagliptin Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Sitagliptin Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Sitagliptin Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Sitagliptin Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Sitagliptin Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Sitagliptin Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Sitagliptin Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Sitagliptin Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Sitagliptin Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Sitagliptin Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Sitagliptin Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Sitagliptin Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Sitagliptin Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Sitagliptin Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Sitagliptin Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Sitagliptin Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Sitagliptin Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yonta
  2. 8.1.1 Yonta Company Information
  3. 8.1.2 Yonta Business Overview
  4. 8.1.3 Yonta Sitagliptin Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yonta Sitagliptin Product Portfolio
  6. 8.1.5 Yonta Recent Developments
  7. 8.2 Baoling Pharma
  8. 8.2.1 Baoling Pharma Company Information
  9. 8.2.2 Baoling Pharma Business Overview
  10. 8.2.3 Baoling Pharma Sitagliptin Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Baoling Pharma Sitagliptin Product Portfolio
  12. 8.2.5 Baoling Pharma Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Sitagliptin Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Sitagliptin Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 De Xiang Pharmaceutical&Chemicals
  20. 8.4.1 De Xiang Pharmaceutical&Chemicals Company Information
  21. 8.4.2 De Xiang Pharmaceutical&Chemicals Business Overview
  22. 8.4.3 De Xiang Pharmaceutical&Chemicals Sitagliptin Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 De Xiang Pharmaceutical&Chemicals Sitagliptin Product Portfolio
  24. 8.4.5 De Xiang Pharmaceutical&Chemicals Recent Developments
  25. 8.5 Haikang Pharma
  26. 8.5.1 Haikang Pharma Company Information
  27. 8.5.2 Haikang Pharma Business Overview
  28. 8.5.3 Haikang Pharma Sitagliptin Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Haikang Pharma Sitagliptin Product Portfolio
  30. 8.5.5 Haikang Pharma Recent Developments
  31. 8.6 Phebra
  32. 8.6.1 Phebra Company Information
  33. 8.6.2 Phebra Business Overview
  34. 8.6.3 Phebra Sitagliptin Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Phebra Sitagliptin Product Portfolio
  36. 8.6.5 Phebra Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sitagliptin Value Chain Analysis
  2. 9.1.1 Sitagliptin Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sitagliptin Sales Mode & Process
  6. 9.2 Sitagliptin Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sitagliptin Distributors
  9. 9.2.3 Sitagliptin Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst